Funny reading all the trolls who are so sure this test is of no use. They all focus on early detection but overlook the fact that even PCR testing has limited early accuracy.
Another key here is that pathology labs have limited capacity and each test costs a chunk of money to collect and process. The govt are throwing billions at stimulating a damaged economy. To test the entire population with a $20 rapid test would cost maybe $600 million. It's not cost prohibitive and the other big tick for this testing method is that you can vastly expand testing capacity. At the moment you need a specialist pathology lab to run the tests but there are hundreds, perhaps thousands of testing centres that are probably capable of meeting the skill requirements to deliver the rapid test. Dr's, nurses and workplace drug and alcohol services could all be stood up to do the rapid testing. It's a way to vastly expand testing and find 'most' who have the virus or who have had it.
I would suggest rather than listening to the HC experts that all do their own research. There are plenty of much smarter people than us on here who are putting out very informative information on the benefits of rapid testing. A few threads from the bird below, note these guys should know a little more that the average HC punter.
Vale delivering 4.5 million Wondfo tests to Brazil
US MD has put together a very informative thread of where, what how and why rapid testing will be adopted
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-633
-
-
- There are more pages in this discussion • 638 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable